Floor Price. The Company agrees that by 31 January 2020, the Company will seek shareholder approval to remove the definition of Floor Price in the Convertible Securities Agreement. If the Company fails to receive shareholder approval, the Investor shall have the right to request repayment of the Amount Outstanding in accordance with clause 3.8(a)(i) of the Convertible Securities Agreement. The Company and the Investor agree and acknowledge that:
Appears in 3 contracts
Sources: Convertible Securities Agreement (G Medical Innovations Holdings Ltd.), Convertible Securities Agreement (G Medical Innovations Holdings Ltd.), Convertible Securities Agreement (G Medical Innovations Holdings Ltd.)
Floor Price. The Company agrees that by 31 January 2020within 90 days of this Amendment Letter, the Company will seek shareholder approval to remove the definition of Floor Price in the Convertible Securities Agreement. If the Company fails to receive shareholder approval, the Investor shall have the right to request repayment of the Amount Outstanding in accordance with clause 3.8(a)(i) of the Convertible Securities Agreement). The Company and the Investor agree and acknowledge that:
Appears in 3 contracts
Sources: Convertible Securities Agreement (G Medical Innovations Holdings Ltd.), Convertible Securities Agreement (G Medical Innovations Holdings Ltd.), Convertible Securities Agreement (G Medical Innovations Holdings Ltd.)